KL

Kanak Lata

Active Director Director DIN 07904186
DIN 07904186 First appointment Sep 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2017
Shareholding value •••• Premium profile

About Kanak Lata

Data last updated:

Kanak Lata is a Director at Aquintis Pharma Private Limited (since 2017). The company operates in Healthcare. Aquintis Pharma Private Limited reported revenue of ₹55.9 Lakh (FY 2025).

DIN 07904186
Primary Designation Director
Industry Healthcare
First Appointment 20 Sep 2017
Oldest Company Age 25 yrs
Largest company Aquintis Pharma Private Limited · ₹55.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aquintis Pharma Private Limited U51397DL2001PTC113119
Director20 Sep 20172001₹55.9 Lakh (FY 2025)Active

Board colleagues of Kanak Lata

NameDINCompanyDesignation
Shekhar Kumar Singh02560676Aquintis Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aquintis Pharma Private Limited
Premium access

Shareholding and investment profile for Kanak Lata

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanak Lata

Kanak Lata currently holds 1 directorship: Aquintis Pharma Private Limited (Director, since 20 Sep 2017, revenue ₹55.9 Lakh (FY 2025)).

Kanak Lata was first appointed on 20 Sep 2017 as Director at Aquintis Pharma Private Limited.

The current boards of Kanak Lata's companies include Shekhar Kumar Singh (Aquintis Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available